Nostrapharma Limited Accounts

Nostrapharma Limited Filleted Accounts Cover
Nostrapharma Limited
Company No. 10456196
Information for Filing with The Registrar
31 May 2021
Nostrapharma Limited Directors Report Registrar
The Director presents her report and the accounts for the year ended 31 May 2021.
Principal activities
The principal activity of the company during the year under review was pharmaceutical consultancy.
Director
The Director who served at any time during the year was as follows:
N. Mihajlovic
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
N. Mihajlovic
Director
15 November 2021
Nostrapharma Limited Balance Sheet Registrar
at
31 May 2021
Company No.
10456196
Notes
2021
2020
£
£
Fixed assets
Tangible assets
5
15,99323,364
15,99323,364
Current assets
Debtors
6
78,7173,475
Cash at bank and in hand
104,79047,585
183,50751,060
Creditors: Amount falling due within one year
7
(71,029)
(23,360)
Net current assets
112,47827,700
Total assets less current liabilities
128,47151,064
Creditors: Amounts falling due after more than one year
8
-
(15,951)
Net assets
128,47135,113
Capital and reserves
Called up share capital
100100
Profit and loss account
9
128,37135,013
Total equity
128,47135,113
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 May 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 15 November 2021
And signed on its behalf by:
N. Mihajlovic
Director
15 November 2021
Nostrapharma Limited Notes to the Accounts Registrar
for the year ended 31 May 2021
1
General information
Its registered number is: 10456196
Its registered office is:
15 Bell Street
Reigate
Surrey
RH2 7AD
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
The accounts have been prepared in accordance with FRS 102 Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland (March 2018) and the Companies Act 2006.
2
Accounting policies
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Revenue from the sale of goods is recognised when all the following conditions are satisfied:
• the Company has transferred to the buyer the significant risks and rewards of ownership of the
goods;
• the Company retains neither continuing managerial involvement to the degree usually associated
with ownership nor effective control over the goods sold;
• the amount of revenue can be measured reliably;
• it is probable that the economic benefits associated with the transaction will flow to the Company;
and
• the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Plant and machinery
25% Straight line
Motor vehicles
25% Straight line
Furniture, fittings and equipment
25% Straight line
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Foreign currencies
The functional and presentational currency of the company is Sterling. The accounts are rounded to the nearest pound.
Transactions in currencies, other than the functional currency of the Company, are recorded at the rate of exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. all differences are taken to the profit and loss account. Non-monetary items that are measured at historic cost in a foreign currency are not retranslated.
Leased assets
Where the company enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.

Leases which do not transfer substantially all the risks and rewards of ownership to the Company are classified as operating leases.

Assets held under finance leases are initially recognised as assets of the Company at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately in profit or loss, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the Company's policy on borrowing costs (see the accounting policy above).

Assets held under finance leases are depreciated in the same way as owned assets.

Operating lease payments are recognised as an expense on a straight-line basis over the lease term.

In the event that lease incentives are received to enter into operating leases, such incentives are recognised as a liability. The aggregate benefit of incentives is recognised as a reduction of rental expense on a straight-line basis.
3
Change in length of the reporting period
The length of the reporting period changed in 2020. Therefore the comparatives are not comparable
4
Employees
2021
2020
Number
Number
The average monthly number of employees (including directors) during the year was:
23
5
Tangible fixed assets
Plant and machinery
Motor vehicles
Fixtures, fittings and equipment
Total
£
£
£
£
Cost or revaluation
At 1 June 2020
6,47730,7455,99443,216
Additions
4,098--4,098
At 31 May 2021
10,57530,7455,99447,314
Depreciation
At 1 June 2020
3,42814,7181,70619,852
Charge for the year
2,3307,6861,45311,469
At 31 May 2021
5,75822,4043,15931,321
Net book values
At 31 May 2021
4,8178,3412,83515,993
At 31 May 2020
3,04916,0274,28823,364
6
Debtors
2021
2020
£
£
Trade debtors
78,717-
Prepayments and accrued income
-3,475
78,7173,475
7
Creditors:
amounts falling due within one year
2021
2020
£
£
Obligations under finance lease and hire purchase contracts
15,6524,253
Trade creditors
21,5674,142
Corporation tax
37,16810,204
Other taxes and social security
(6,211)
4,234
Loans from directors
137527
Other creditors
1,125-
Accruals and deferred income
1,591-
71,02923,360
8
Creditors:
amounts falling due after more than one year
2021
2020
£
£
Obligations under finance lease and hire purchase contracts
-15,951
-15,951
9
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
Nostrapharma Limited1045619631 May 202101 June 2020false15 November 2021BTCSoftware AP Solution 2021 8.3.028.3.02true104561962020-06-012021-05-31104561962021-05-31104561962020-05-3110456196core:WithinOneYear2021-05-3110456196core:WithinOneYear2020-05-3110456196core:AfterOneYear2021-05-3110456196core:AfterOneYear2020-05-3110456196core:ShareCapital2021-05-3110456196core:ShareCapital2020-05-3110456196core:RetainedEarningsAccumulatedLosses2021-05-3110456196core:RetainedEarningsAccumulatedLosses2020-05-3110456196bus:RegisteredOffice2020-06-012021-05-3110456196core:PlantMachinery2020-06-012021-05-3110456196core:MotorVehicles2020-06-012021-05-3110456196core:FurnitureFittingsToolsEquipment2020-06-012021-05-31104561962018-12-012020-05-3110456196core:PlantMachinery2020-06-0110456196core:MotorVehicles2020-06-0110456196core:FurnitureFittingsToolsEquipment2020-06-01104561962020-06-0110456196core:PlantMachinery2021-05-3110456196core:MotorVehicles2021-05-3110456196core:FurnitureFittingsToolsEquipment2021-05-3110456196core:PlantMachinery2020-05-3110456196core:MotorVehicles2020-05-3110456196core:FurnitureFittingsToolsEquipment2020-05-3110456196core:RetainedEarningsAccumulatedLosses2020-06-012021-05-3110456196bus:SmallEntities2020-06-012021-05-3110456196bus:FullAccounts2020-06-012021-05-3110456196bus:AuditExempt-NoAccountantsReport2020-06-012021-05-3110456196bus:Director12020-06-012021-05-3110456196bus:PrivateLimitedCompanyLtd2020-06-012021-05-31iso4217:GBPxbrli:pure